Items Tagged ‘iressa’

November 8th, 2016

Personalized Lung Cancer Care & Precision Medicine

By

Targeted and more-individualized treatment for NSCLC becomes a reality. Lung cancers used to be diagnosed solely by a visual microscopic examination of tumor tissue and all patients received the same chemotherapy. Now, doctors are personalizing care by finding the genetic alterations within the cancer that drive its growth and then use medicines that specifically counteract […]

View full entry

Tags: Alcensa, ALK mutation, EGFR, General Lung Cancer, gilotrif, iressa, Lung Cancer, Lung Cancer - Non-Small Cell, Lung Cancer - Small Cell, Necitumumab, News, nsclc


September 23rd, 2015

Iressa® Approved as Initial Therapy for Lung Cancer

By

The targeted agent Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration (FDA) as initial therapy in the treatment of patients with advanced lung cancer. Specifically, Iressa was approved as initial therapy for the treatment of patients with advanced non-small cell lung cancer (NSCLC) with specific mutations within the EGFR pathway. The […]

View full entry

Tags: advanced lung cancer, EGFR mutations, EGFR RGQ PCR Kit, FDA approval, gefitinib, iressa, Lung Cancer - Non-Small Cell, News, nsclc, Stages IIIB-IV Lung Cancer - Non-Small Cell


December 4th, 2014

Esophageal Cancer Survival Improved Using Targeted Therapy Developed in Lung Cancer

By

Targeted therapy commonly used in lung cancer improves survival of esophageal cancer patients according to clinical trial results recently presented at the National Cancer Research Institute (NCRI) Cancer Conference in the UK. The esophagus is a muscular tube that food and liquids pass through on their on their way to the stomach. Each year in the […]

View full entry

Tags: EGFR, Esophageal Cancer, iressa, News, Stage IV/Recurrent Esophageal Cancer